These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 37725985)

  • 21. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidics applications for high-throughput single cell sequencing.
    Zhou WM; Yan YY; Guo QR; Ji H; Wang H; Xu TT; Makabel B; Pilarsky C; He G; Yu XY; Zhang JY
    J Nanobiotechnology; 2021 Oct; 19(1):312. PubMed ID: 34635104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing Cancer Research and Medicine with Single-Cell Genomics.
    Lim B; Lin Y; Navin N
    Cancer Cell; 2020 Apr; 37(4):456-470. PubMed ID: 32289270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluidic Single-Cell Omics Analysis.
    Xu X; Wang J; Wu L; Guo J; Song Y; Tian T; Wang W; Zhu Z; Yang C
    Small; 2020 Mar; 16(9):e1903905. PubMed ID: 31544338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in single cell manipulation and biochemical analysis on microfluidics.
    Gao D; Jin F; Zhou M; Jiang Y
    Analyst; 2019 Jan; 144(3):766-781. PubMed ID: 30298867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances of Utilizing Artificial Intelligence in Lab on a Chip for Diagnosis and Treatment.
    Zare Harofte S; Soltani M; Siavashy S; Raahemifar K
    Small; 2022 Oct; 18(42):e2203169. PubMed ID: 36026569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
    Kanzaki R; Pietras K
    Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Approaches for the Investigation of Intra-tumor Heterogeneity and Clonal Evolution from Bulk Sequencing Data in Precision Oncology Applications.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():101-118. PubMed ID: 35230685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics.
    Yan S; Guo Y; Lin L; Zhang W
    Cancer Biother Radiopharm; 2024 Feb; 39(1):35-45. PubMed ID: 38181185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput single-сell sequencing in cancer research.
    Jia Q; Chu H; Jin Z; Long H; Zhu B
    Signal Transduct Target Ther; 2022 May; 7(1):145. PubMed ID: 35504878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microdissected "cuboids" for microfluidic drug testing of intact tissues.
    Horowitz LF; Rodriguez AD; Au-Yeung A; Bishop KW; Barner LA; Mishra G; Raman A; Delgado P; Liu JTC; Gujral TS; Mehrabi M; Yang M; Pierce RH; Folch A
    Lab Chip; 2021 Jan; 21(1):122-142. PubMed ID: 33174580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review on microfluidics manipulation of the extracellular chemical microenvironment and its emerging application to cell analysis.
    Chen P; Li S; Guo Y; Zeng X; Liu BF
    Anal Chim Acta; 2020 Aug; 1125():94-113. PubMed ID: 32674786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell sequencing technologies in bladder cancer research: Applications and challenges.
    Lyu T; Lin Y; Wu K; Cao Z; Zhang Q; Zheng J
    Front Genet; 2022; 13():1027909. PubMed ID: 36338973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Microfluidic and Biosensor Technologies for Improved Cancer Theranostics.
    Caballero D; Abreu CM; Reis RL; Kundu SC
    Adv Exp Med Biol; 2022; 1379():461-495. PubMed ID: 35761004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of precision medicine in modern molecular oncology.
    Wang Y; Zheng D
    Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in microfluidics for single-cell functional proteomics.
    Gebreyesus ST; Muneer G; Huang CC; Siyal AA; Anand M; Chen YJ; Tu HL
    Lab Chip; 2023 Mar; 23(7):1726-1751. PubMed ID: 36811978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.